SetPoint Medical and Lovell Government Services Partner to Expand Access to Innovative Rheumatoid Arthritis Therapy

Lovell Government Services and SetPoint Medical partner to deliver FDA-approved neuroimmune therapy for rheumatoid ...

AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics

AnaptysBio has spun off its biopharma pipeline into First Tracks Biotherapeutics, shifting to a royalty-focused, virtual ...

Rising Demand Drives Sculptra Adoption in Aesthetic Clinics

Cypress Clinic Expands Collagen-Stimulating Treatments With Sculptra Cypress, United States - April 17, 2026 / Skin ...
Fierce Pharma

AstraZeneca eyes 5th Ultomiris indication after kidney disease trial win

Already approved to treat four rare diseases, AstraZeneca’s Ultomiris has shown its ability against another rare disorder, ...

AstraZeneca's tozorakimab delivers reduction in chronic lung disease flare‑ups

AstraZeneca said on Monday its ‌experimental treatment tozorakimab showed a "meaningful reduction" in moderate-to-severe ...
Clinical Advisor

Short-Term GLP-1 RA Use Linked to Higher Risk for New-Onset Rheumatoid Arthritis

Researchers conducted a nationwide, case-control study to explore the relationship between GLP-1 RA use and the risk of developing rheumatoid arthritis.
Everyday Health

How Rheumatoid Arthritis Affects Body Image

The physical and psychological effects of RA may impact self-perception. Effective treatment and strategies like mindfulness, ...
CURE

FDA Approves Generic Methotrexate Injection for Multiple Cancer Types

This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat ...
Everyday Health

5 Iced Tea Recipes for Rheumatoid Arthritis Symptom Relief

Loaded with antioxidants and anti-inflammatory properties, iced tea may help with rheumatoid arthritis. Find recipes for mint ...

Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers

Expanded treatment in community settings will reduce patient burdenOption to redose patients granted in both Ntrust-1 and Ntrust-2 ...

Breakthrough Drug Delays Rheumatoid Arthritis for Years After Treatment Ends

A long-term clinical study suggests that intervening before rheumatoid arthritis fully develops may significantly alter its ...

Dogwood Therapeutics, Inc.: Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy

Dogwood licensed SP16 to treat cancer-related pain from partner and regulatory sponsor Serpin Pharma The SP16 Phase 1b trial fully funded by the National Cancer Institute; Patient enrollment expected ...